Optic Neuropathy and Other Hidden Ocular Risks of GLP-1 RA Weight Loss Drugs - Neurology Advisor
  China Develops New Anti-Obesity Drugs with Added Benefits for Heart, Liver, and Diabetes - jordannews.jo
  A new chapter for online sales of obesity drug alternatives tests legal limits - NPR
  Eli Lilly says India response to obesity drug Mounjaro is 'positive', will focus on meeting demand - Reuters
  Beyond Ozempic: New weight loss drug rivals surgery - ScienceDaily
  Chinese Biotech Showcases Challenger to Eli Lilly’s Obesity Drug - Bloomberg
  Eli Lilly's experimental obesity drug shows over 11% weight loss in early trial - Reuters
  Beyond the scale: redefining success in obesity drug market - Nature